
Sign up to save your podcasts
Or
What if you submit your 510(k), IDE, or other submission type to FDA only to get an additional information request (AI request)? What do you do for requests that seem overly burdensome? Thanks to a new FDA pilot program known as the Least Burdensome Flag, manufacturers now have a process and methodology they can deploy if and when this scenario arises.
In this episode of the Global Medical Device Podcast host Jon Speer talks to guest Mike Drues, President of Vascular Sciences, about the ways in which manufacturers should approach responding to AI requests via the Least Burdensome Flag program from FDA CDRH.
Some of the highlights of this episode include:“Why is FDA asking us to do this additional testing, collect this additional data, whatever? FDA should be able to give you a legitimate reason as to why they’re looking for this information.”
“We should respect the FDA, but at the same time, they should respect us.”
“The goal of the Least Burdensome Flag is to quickly address FDA requests.” “Whatever we do, that needs to be justified. There needs to be a reason for doing it...needs to be justified based on the biology and engineering.”
Links:Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions
FDA/CDRH Webinar - The Least Burdensome Provisions: Concept and Principles
510(k) Submission Process
Investigational Device Exemption (IDE)
ISO 10993 - Biological Evaluation of Medical Devices
Code of Federal Regulations (CFR)
Medical Device User Fee Amendments (MDUFA)
Mike Drues on LinkedIn
Greenlight Guru Academy
The Greenlight Guru True Quality Virtual Summit
MedTech True Quality Stories Podcast
Greenlight Guru YouTube Channel
Greenlight Guru
What if you submit your 510(k), IDE, or other submission type to FDA only to get an additional information request (AI request)? What do you do for requests that seem overly burdensome? Thanks to a new FDA pilot program known as the Least Burdensome Flag, manufacturers now have a process and methodology they can deploy if and when this scenario arises.
In this episode of the Global Medical Device Podcast host Jon Speer talks to guest Mike Drues, President of Vascular Sciences, about the ways in which manufacturers should approach responding to AI requests via the Least Burdensome Flag program from FDA CDRH.
Some of the highlights of this episode include:“Why is FDA asking us to do this additional testing, collect this additional data, whatever? FDA should be able to give you a legitimate reason as to why they’re looking for this information.”
“We should respect the FDA, but at the same time, they should respect us.”
“The goal of the Least Burdensome Flag is to quickly address FDA requests.” “Whatever we do, that needs to be justified. There needs to be a reason for doing it...needs to be justified based on the biology and engineering.”
Links:Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions
FDA/CDRH Webinar - The Least Burdensome Provisions: Concept and Principles
510(k) Submission Process
Investigational Device Exemption (IDE)
ISO 10993 - Biological Evaluation of Medical Devices
Code of Federal Regulations (CFR)
Medical Device User Fee Amendments (MDUFA)
Mike Drues on LinkedIn
Greenlight Guru Academy
The Greenlight Guru True Quality Virtual Summit
MedTech True Quality Stories Podcast
Greenlight Guru YouTube Channel
Greenlight Guru